X0202 4 2008-06-10 0 0001088856 CORCEPT THERAPEUTICS INC CORT 0001024003 COOK JOSEPH C JR C/O CORCEPT THERAPEUTICS INCORPORATED 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 1 0 0 0 Common Stock 484600 I By Joint Account Common Stock 995238 I By Farview Mgmt Co. Common Stock 176522 I By GRAT Stock option (right to buy) 7.00 2012-04-17 Common Stock 50000 50000 D Stock Option (right to buy) 7.00 2013-11-23 Common Stock 25000 25000 D Stock option (right to buy) 2.70 2017-12-19 Common Stock 15000 15000 D Warrants 2.77 2008-03-25 2015-03-24 Common Stock 88261 88261 I By GRAT Stock Option (right to buy) 2.23 2008-06-10 4 A 0 15000 2.23 A 2018-06-10 Common Sotck 15000 15000 D These securities are held by Farview Management Co., LLP, of which the reporting person is a general partner. Immediately exercisable subject to a right of repurchase by Corcept Therapeutics Incorporated that shall lapse at the rate of 20% of the total option shares on 4/17/2003 and an additional 1.67% of the total option shares on each monthly anniverary of 4/17/2003 thereafter. Immediately exercisable subject to a right of repurchase by Corcept Therapeutics Incorporated that shall lapse at the rate of 20% of the total option shares on 11/23/2004 and an additional 1.67% of the total option shares on each monthly anniverary of 11/23/2004 thereafter. Exercisable with respect to 8.3334% of the total option shares on each monthly anniversary of June 11, 2007 so that the entirety of the option grant will vest within one year. Exercisable with respect to 8.3334% of the total option shares on each monthly anniversary of June 10, 2008 so that the entirety of the option grant will vest within one year. /s/ Joseph K. Belanoff, CEO of Corcept Therapeutics Incorporated attorney-in-fact 2008-06-11